SNWV
SANUWAVE Health, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$4.38
−1.57%Year over year
Reported trailing growth
- Revenue
- +12.0%
- EBITDA
- +172.1%
- EBIT
- -90.8%
- EPS
- +115.9%
- Free cash flow
- +5935.8%
- Operating cash flow
- +248.4%
Forward estimates
Based on analyst estimates
- Revenue
- +3.1%
- EBITDA
- -38.9%
- EPS
- -55.4%
Three-year CAGR
- Revenue
- +38.1%
- EBITDA
- +59.4%
- EBIT
- -8.7%
- Net income
- +137.7%
- EPS
- +119.6%
- Free cash flow
- -1.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026